H. Ling; R. Spizzo; Y. Atlasi; M. Nicoloso; M. Shimizu; R. S. Redis; N. Nishida; R. Gafa; J. Song; Z. Guo; C. Ivan; E. Barbarotto; I. De Vries; X. Zhang; M. Ferracin; M. Churchman; J. F. van Galen; B. H. Beverloo; M. Shariati; F. Haderk; M. R. Estecio; G. Garcia-Manero; G. A. Patijn; D. C. Gotley; V. Bhardwaj; I. Shureiqi; S. Sen; A. S. Multani; J. Welsh; K. Yamamoto; I. Taniguchi; M.-A. Song; S. Gallinger; G. Casey; S. N. Thibodeau; L. Le Marchand; M. Tiirikainen; S. A. Mani; W. Zhang; R. V. Davuluri; K. Mimori; M. Mori; A. M. Sieuwerts; J. W. M. Martens; I. Tomlinson; M. Negrini; I. Berindan-Neagoe; J. A. Foekens; S. R. Hamilton; G. Lanza; S. Kopetz; R. Fodde; G. A. Calin, CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer, «GENOME RESEARCH», 2013, 23, pp. 1446 - 1461 [Scientific article]
F. Morabito; L. Mosca; G. Cutrona; L. Agnelli; G. Tuana; M. Ferracin; B. Zagatti; M. Lionetti; S. Fabris; F. Maura; S. Matis; M. Gentile; E. Vigna; M. Colombo; C. Massucco; A. G. Recchia; S. Bossio; L. De Stefano; F. Ilariucci; C. Musolino; S. Molica; F. Di Raimondo; A. Cortelezzi; P. Tassone; M. Negrini; S. Monti; D. Rossi; G. Gaidano; M. Ferrarini; A. Neri, Clinical Monoclonal B lymphocytosis versus Rai 0 Chronic Lymphocytic Leukemia: a Comparison of Cellular, Cytogenetic, Molecular, and Clinical Features, «CLINICAL CANCER RESEARCH», 2013, 19, pp. 5890 - 5900 [Scientific article]
Wang LQ; Kwong YL; Kho CS; Wong KF; Wong KY; Ferracin M; Calin GA; Chim CS, Epigenetic inactivation of miR-9 family microRNAs in chronic lymphocytic leukemia--implications on constitutive activation of NFκB pathway., «MOLECULAR CANCER», 2013, 12, pp. 1 - 1 [Scientific article]
Lucherini OM; Obici L; Ferracin M; Fulci V; McDermott MF; Merlini G; Muscari I; Magnotti F; Dickie LJ; Galeazzi M; Negrini M; Baldari CT; Cimaz R; Cantarini L, First report of circulating microRNAs in tumour necrosis factor receptor-associated periodic syndrome (TRAPS)., «PLOS ONE», 2013, 8, Article number: e73443 , pp. 1 - 6 [Scientific article]Open Access
J Ferdin; N Nishida; X Wu; M S Nicoloso; M Y Shah; C Devlin; H Ling; M Shimizu; K Kumar; M A Cortez; M Ferracin; Y Bi; D Yang; B Czerniak; W Zhang; T D Schmittgen; M P Voorhoeve; M J Reginato; M Negrini; R V Davuluri; T Kunej; M Ivan; G A Calin, HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts, «CELL DEATH AND DIFFERENTIATION», 2013, 20, pp. 1675 - 1687 [Scientific article]
M. Ferracin; C. Bassi; M. Pedriali; S. Pagotto; L. D’Abundo; B. Zagatti; F. Corrà; G. Musa; E. Callegari; L. Lupini; S. Volpato; P. Querzoli; M. Negrini, miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression, «MOLECULAR CANCER», 2013, 12, pp. 130 - 130 [Scientific article]
Nadia Felli; Federica Felicetti; Anna Maria Lustri; M. Cristina Errico; Lisabianca Bottero; Alessio Cannistraci; Alessandra De Feo; Marina Petrini; Francesca Pedini; Mauro Biffoni; Ester Alvino; Massimo Negrini; Manuela Ferracin; Gianfranco Mattia; Alessandra Carè, miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma, «PLOS ONE», 2013, 8, pp. 1 - 15 [Scientific article]Open Access
Lupini L.; Bassi C.; Ferracin M.; Bartonicek N.; D'Abundo L.; Zagatti B.; Callegari E.; Musa G.; Moshiri F.; Gramantieri L.; Corrales F.J.; Enright A.J.; Sabbioni S.; Negrini M., miR-221 affects multiple cancer pathways by modulating the level of hundreds messenger RNAs, «FRONTIERS IN GENETICS», 2013, 4, pp. 64 - 64 [Scientific article]
G. Ciancio; M. Ferracin; M. Negrini; M. Govoni, The Role of Micro-RNAs in Rheumatic Diseases: An Update, in: Innovative Rheumatology, London, InTech, 2013, pp. 51 - 69 [Chapter or essay]
Callegari E.; Elamin B.K.; Giannone F.; Milazzo M.; Altavilla G.; Fornari F.; Giacomelli L.; D'Abundo L.; Ferracin M.; Bassi C.; Zagatti B.; Corrà F.; Miotto E.; Lupini L.; Bolondi L; Gramantieri L.; Croce C.M.; Sabbioni S.; Negrini M., Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model, «HEPATOLOGY», 2012, 56, pp. 1025 - 1033 [Scientific article]
Ferracin M.; Negrini M., MicroRNAs and Their Role in Cancer, in: -, eLS, Hoboken, John Wiley & Sons, 2012, pp. - - - [Chapter or essay]
Nakatani F.; Ferracin M.; Manara M.C.; Ventura S.; del Monaco V.; Ferrari S.; Alberghini M.; Grilli A.; Knuutila S.; Schaefer K.L.; Mattia G.; Negrini M.; Picci P.; Serra M.; Scotlandi K., miRNA signature predicts survival of Ewing’s sarcoma patients and miR34a directly influences cell chemosensitivity and malignancy, «JOURNAL OF PATHOLOGY», 2012, 226, pp. 796 - 805 [Scientific article]
S. Formica; A. Astolfi; M. Nannini; M. A. Pantaleo; M. Ferracin; B. Zagatti; M. Negrini; D. Santini; P. Paterini; M. di Battista; A. Maleddu; M. Saponara; M. C. Pallotti; A. Mandrioli; C. Lolli; F. Catena; A. P. Dei Tos; G. Biasco, MicroRNA profile in gastrointestinal stromal tumors (GISTs) and correlation with KIT/PDGFRA kinase genotype., in: na, «JOURNAL OF CLINICAL ONCOLOGY», 2011, 29, pp. 10056 - 10056 (atti di: 2011 ASCO Annual Meeting, Chicago, 2011 June 3-7) [Abstract]
M. Ferracin; M. Pedriali; A. Veronese; B. Zagatti; R. Gafà; E. Magri; M. Lunardi; G. Munerato; G. Querzoli; I. Maestri; L. Ulazzi; I. Nenci; C.M. Croce; G. Lanza; P. Querzoli; M. Negrini, MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin, «JOURNAL OF PATHOLOGY», 2011, 225, pp. 45 - 53 [Scientific article]
Narducci M.G.; Arcelli D.; Picchio M.C.; Lazzeri C.; Pagani E.; Sampogna F.; Scala E.; Fadda P.; Cristofoletti C.; Facchiano A.; Frontani M.; Monopoli A.; Ferracin M.; Negrini M.; Lombardo G.A.; Caprini E.; Russo G., MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome, «CELL DEATH & DISEASE», 2011, 2, pp. 151 - 151 [Scientific article]
